|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0220 USD | +4.76% |
|
+4.76% | -94.50% |
Company Valuation: Telesis Bio, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 316.5 | 35.43 | 11.96 |
| Change | - | -88.81% | -66.23% |
| Enterprise Value (EV) 1 | 251 | 13.28 | 27.19 |
| Change | - | -94.71% | 104.79% |
| P/E ratio | -5.05x | -0.73x | -0.24x |
| PBR | 3.49x | 0.76x | 50.4x |
| PEG | 0.1x | 0x | 1.42x |
| Capitalization / Revenue | 28.7x | 1.29x | 0.43x |
| EV / Revenue | 22.7x | 0.48x | 0.99x |
| EV / EBITDA | -7.35x | -0.3x | -0.83x |
| EV / EBIT | -7.16x | -0.29x | -0.77x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -38.48 | -29.61 | -29.56 |
| Distribution rate | - | - | - |
| Net sales 1 | 11.04 | 27.44 | 27.51 |
| EBITDA 1 | -34.17 | -44.81 | -32.83 |
| EBIT 1 | -35.07 | -46.48 | -35.15 |
| Net income 1 | -38.96 | -48.47 | -47.72 |
| Net Debt 1 | -65.48 | -22.15 | 15.22 |
| Reference price 2 | 194.3998 | 21.6000 | 7.1820 |
| Nbr of stocks (in thousands) | 1,628 | 1,640 | 1,666 |
| Announcement Date | 23/03/22 | 22/03/23 | 29/03/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 39.64K | ||
| 32.09x | 5.49x | 21.76x | 0.29% | 215B | ||
| 76.29x | 20.04x | 46.79x | -.--% | 204B | ||
| 43.49x | 7.06x | 22.81x | 0.55% | 160B | ||
| 47.22x | 7.64x | 24.94x | -.--% | 145B | ||
| 20.67x | 2.44x | 11.86x | 2.35% | 56.48B | ||
| 37.49x | 7.75x | 25.65x | -.--% | 50.02B | ||
| 32.61x | 6.19x | 22.06x | 0.67% | 41.18B | ||
| 18.66x | 2.15x | 12.09x | 0.17% | 38.93B | ||
| 24.46x | 6.45x | 16.7x | 0.94% | 37.39B | ||
| Average | 37.00x | 7.25x | 22.74x | 0.55% | 94.75B | |
| Weighted average by Cap. | 44.61x | 9.08x | 26.84x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- TBIO Stock
- Valuation Telesis Bio, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















